Neutral and Acid Sphingomyelinases of Rat Brain: Somatotopographical Distribution and Activity Following Experimental Manipulation of the Dopaminergic System In Vivo
- 1 April 1983
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 40 (4) , 1182-1184
- https://doi.org/10.1111/j.1471-4159.1983.tb08112.x
Abstract
The activities of neutral, magnesium‐stimulated, and acid Sphingomyelinases were measured in five regions of rat brain. Neutral enzyme activity was 2‐3‐fold higher in striatum than in parietal cortex and 13‐fold higher than in cerebral white matter. Acid sphingomyelinase activity was more evenly distributed throughout these regions. Striatal neutral sphingomyelinase activity was not affected by treatment of rats with reserpine or haloperidol and was reduced (16%) by 6‐hydroxydopamine. Striatal acid sphingomyelinase was unaffected by reserpine and 6‐hydroxydopamine, and was increased (17%) by haloperidol. We conclude that neutral, magnesium‐stimulated sphingomyelinase activity differs in various regions of rat brain and is particularly enriched in the corpus striatum. However, it appears to be a constitutive component of tissue rather than a readily modulated regulatory element of the catecholaminergic system.Keywords
This publication has 14 references indexed in Scilit:
- Neutral and acid sphingomyelinases: Somatotopographical distribution in human brain and distribution in rat organs. A possible relationship with the dopamine systemBrain Research, 1979
- Acid and neutral sphingomyelinases of rat brain. Activity in developing brain and regional distribution in adult brainJournal of Neurochemistry, 1978
- Dopamine, a modulator of carbohydrate metabolism in the caudate nucleusBrain Research, 1977
- Magnesium-dependent sphingomyelinaseBiochemical and Biophysical Research Communications, 1976
- Interaction Between Dopamine and PhospholipidsArchives of Neurology, 1975
- L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa TherapyNature, 1973
- A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areasAnalytical Biochemistry, 1971
- Histochemistry of Adrenal Bodies in Parkinson's DiseaseArchives of Neurology, 1970
- Sphingomyelin in Lewy Inclusion Bodies in Parkinson's DiseaseArchives of Neurology, 1969
- Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-SyndromKlinische Wochenschrift, 1961